Skip to main content
Premium Trial:

Request an Annual Quote

Lonza, SRU Biosystems

Premium
Lonza has developed new Amaxa Nucleofector kits for the transfection of primary mouse B cells, from single reactions up to 96-well transfections, the company announced this week.
 
Results of up to 74 percent transfection efficiency for stimulated mouse B cells and a viability of 59 percent for human hepatocytes 120 hours post nucleofection have been achieved, the company said.
 
New Amaxa Nucleofector kits are also available for the transfection of human hepatocytes and human chondrocytes.
 

 
SRU Biosystems this week announced the launch and first commercial sale of its recently introduced Cartridge Reader to an undisclosed academic laboratory.
 
The Cartridge Reader is the company’s entry-level instrument for assay development and low-throughput applications to cellular and biochemical studies based on 8- and 16-well label-free biosensors.
 
The Cartridge Reader can be applied to cell assay development for GPCR, adhesion, and ion channel assays using over-expressed or endogenous systems. In addition, the design of the cartridges and optics of the system allow for the use of low numbers of cells, such as primary cells or stem cells.
 
The Cartridge Reader can also be used by biochemists and chemists to perform binding analysis of compounds — small molecules or fragments — with target proteins together with SRU’s different surface chemistries. The cartridges are built on standard SRU BIND biosensors and come in a variety of configurations for assay development.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.